BioWorld’s suite of news services delivers actionable intelligence on the most innovative therapeutics and medical technologies in development. With writers and editors stationed around the globe, BioWorld reports the breaking news – and provides key perspective on hundreds of therapeutics and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. BioWorld The flagship daily biopharmaceutical news source covers the complete lifecycle of thousands of therapies in development from around the world, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. Includes data-rich content focused on financial and strategic trends with deep analysis that helps decision makers develop dynamic strategies. BioWorld MedTech The news source of record covering the latest advances in medical technologies from around the world ranging from actual devices, such as orthopedic implants, to digital health tools. BioWorld Science News and analysis on discovery and preclinical research to support crucial drug R&D decisions at the earliest stages. BioWorld Asia The weekly monitor of biopharmaceutical developments in the Asia-Pacific region

Website

https://www.bioworld.com/

External link for BioWorld News

Industry

Media and Telecommunications

Company size

11-50 employees

Type

Public Company

Founded

1990